Search clinical trials for: anecortave acetate

Total 3957 results

Alcon Research

Completed

A Phase II Study of Anecortave Acetate for the Treatment of Exudative Age-Related Macular Degeneration

AMD
Alcon Research

Completed

Anecortave Acetate in Patients With Exudative Age-related Macular Degeneration (AMD)

Macular Degeneration

United States
Alcon Research

Terminated

Anecortave Acetate Risk-Reduction Trial (AART)

AMD

United States
Alcon Research

Terminated

A Dose-Volume Study of a Treatment for Elevated IOP Due to Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open-Angle Glaucoma

United States
Alcon Research

Completed

Anecortave Acetate Safety in Patients With Open-Angle Glaucoma or Ocular Hypertension

Open-angle Glaucoma | Oular Hypertension

United States
Alcon Research

Completed

Anecortave Acetate in Patients With Open-angle Glaucoma

Open-angle Glaucoma
Alcon Research

Completed

Anecortave Acetate for Treatment of Steroid Induced Intraocular Pressure (IOP) Elevation

Eye Diseases

Spain, United States, Hungary, Brazil, Italy, Netherlands, Puerto Rico, United Kingdom
Alcon Research

Terminated

Anecortave Acetate Risk Reduction Trial (AART)

AMD

India
Cornea Research Foundation of America

Terminated

Anecortave Acetate Injection to Treat Steroid-responsive Intraocular Pressure Increase in Cornea Transplant Patients

Intraocular Pressure | Transplant

United States
Alcon Research

Completed

Safety and Efficacy of Anecortave Acetate in Patients With Open-Angle Glaucoma

Open-angle Glaucoma

United States
Alcon Research

Completed

Anecortave Acetate in Subfoveal Choroidal Neovascularization (CNV) Due to Wet Age-Related Macular Degeneration (AMD)

Macular Degeneration | Age-Related Maculopathies | Age-Related Maculopathy | Maculopathies, Age-Related | Maculopathy, Age-Related
Manhattan Eye, Ear & Throat Hospital
Alcon Research; LuEsther T. Mertz Retinal Research Center

Completed

Treatment of Chronic Central Serous Chorioretinopathy With Open-Label Anecortave Acetate (CSC-AA)

Chronic Central Serous Chorioretinopathy

United States
Alcon Research

Terminated

Anecortave Acetate Risk-Reduction Trial (AART)

Dry AMD

United States
Federal University of São Paulo
Alcon Research

Unknown

IOP Reduction After Anecortave Acetate Injection in Glaucoma Patients

Glaucoma | Intraocular Pressure

Brazil
Alcon Research

Completed

An Evaluation of Safety and Efficacy of Anecortave Acetate Versus Placebo in Patients With Subfoveal CNV Due to Exudative AMD

Macular Degeneration | Maculopathy, Age-Related

United States
Manhattan Eye, Ear & Throat Hospital
Alcon Research

Completed

Treatment of Congenital Telangiectasia (Coat's Disease) With Open-label Anecortave Acetate (15mg.)

Coat's Disease

United States
Manhattan Eye, Ear & Throat Hospital
Alcon Research

Completed

Treatment of Idiopathic Perifoveal Telangiectasia (IPT) With Open-Label Anecortave Acetate (15mg.).

Idiopathic Perifoveal Telangiectasia

United States
Alcon Research

Completed

Anecortave Acetate Versus Placebo in AMD Patients Following PDT

AMD

United States
Alcon Research

Withdrawn

A Multi-Dose Study With a Treatment for Open-Angle Glaucoma

Open-Angle Glaucoma
Manhattan Eye, Ear & Throat Hospital
Alcon Research

Terminated

Treatment of Rubeosis Iridis With Open-Label Anecortave Acetate Sterile Suspension ( 15 mg.).

Central Retinal Vein Occlusion | Severe Diabetic Retinopathy | Chronic Inflammation | Infectious Diseases

United States
Manhattan Eye, Ear & Throat Hospital
Alcon Research

Completed

Treatment of Conditions With Open Label-Anecortave Acetate Sterile Suspension ( 15mg.) Where Lesions do Not Meet Acceptable Criteria for Standard Care.

Age-Related Macular Degenerations. | Subfoveal Neovascularization.

United States
University of Iowa

No longer available

Treatment of Patients With Age-Related Macular Degeneration With Anecortave Acetate

Macular Degeneration

United States
Manhattan Eye, Ear & Throat Hospital
Alcon Research

Withdrawn

Treatment of Retinal Vein Occlusion (RVO) With Open-Label Anecortave Acetate (15mg.)

Retinal Vein Occlusion

United States
Manhattan Eye, Ear & Throat Hospital
Alcon Research

Terminated

Treatment of Radiation Retinopathy With Open-Label Anecortave Acetate Sterile Suspension (15 mg)

Eye Injuries

United States
Texas Retina Associates
Alcon Research

Completed

Prophylactic Anecortave Acetate in Patients With a Retisert Implant

Glaucoma | Uveitis, Posterior

United States
Manhattan Eye, Ear & Throat Hospital
Alcon Research

Completed

Treatment of Pseudovitellium Detachment With Open-Label Anecortave Acetate Sterile Suspension (15 mg)

Eye Diseases | Pseudovitellium Detachment

United States
Manhattan Eye, Ear & Throat Hospital
Alcon Research

Terminated

Treatment of Diabetic Retinopathy With Open-Label Anecortave Acetate Sterile Suspension (15 mg)

Diabetic Retinopathy

United States
Alcon Research

Terminated

Open-Label Posterior Juxtascleral Injections of Anecortave Acetate 15mg Dose for Long Term Use in Patients With AMD

Macular Degeneration

United States
Manhattan Eye, Ear & Throat Hospital
Alcon Research

Completed

Treatment of Age-Related Macular Degeneration With Anecortave Acetate

Macular Degeneration

United States
Alcon Research

Completed

Phase 3 Study to Evaluate Anecortave Acetate vs. Visudyne for the Treatment of the Wet Form of AMD

Macular Degeneration

United States
Courtney Casserly

Recruiting

Fampridine-SR and Optic Neuritis Recovery (FAMP-ON)

Optic Neuritis

Canada
Manhattan Eye, Ear & Throat Hospital
Alcon Research

Completed

Study of the Combination of Anecortave Acetate and Triamcinolone Acetonide for the Treatment of Exudative Age-Related Macular Degeneration (AMD)

Maculopathy, Age-Related

United States
Karolinska Institutet

Completed

Hemodynamic Effects of Cold Versus Warm Fluid Bolus

Temperature Change, Body | Hypovolemia

Sweden
Baylor University

Completed

The Effect of Fish Oil Supplementation on Vocal Performance

Body Composition | Voice Range Profile | Reflux Symptom Index | Evaluation of Ability to Sing Easily

United States
Joachim Zdolsek

Recruiting

Fluid Challenge and Plasma Volume, During Surgery (FC-VE)

Gynecologic Cancer | Colorectal Cancer | Colorectal Disorders | Urologic Cancer | Benign Neoplasm

Sweden
Wendell Yap, MD
University of Kansas Medical Center

No longer available

Clinical Management Decisions for Recurrent Prostate Cancer Patients Based on [11C]Acetate PET Scan

Prostate Cancer

United States
University of Michigan
National Institutes of Health (NIH)

Completed

The Impact of Zinc Supplementation on Left Ventricular Function in Nonischemic Cardiomyopathy

Heart Failure | Cardiomyopathies

United States
Uppsala University

Terminated

Effects of Restrictive Fluid Strategy on Postoperative Oliguric Pancreatic Surgery Patients

Postoperative Complications | Fluid Therapy | Fluid Overload | Pancreas Disease | Postoperative Period

Sweden
Jonsson Comprehensive Cancer Center

No longer available

C11 Sodium Acetate PET/CT Imaging of PCa

Prostate Cancer

United States
Vanderbilt University Medical Center

Completed

Balanced Solutions and Plasma Electrolytes (BASE)

Critical Illness | Acidosis, Metabolic

United States
Daniel Vaena

Completed

PET Acetate for Castrate-Resistant Prostate Cancer on Chemotherapy

Prostate Cancer | Castrate Resistant Prostate Cancer

United States
Phoenix Molecular Imaging

Completed

PET Imaging Characteristics of C11-Acetate in Patients With Recurrent Prostate Carcinoma

Prostate Cancer

United States
University of Texas Southwestern Medical Center
National Cancer Institute (NCI); Howard Hughes Medical Institute

Recruiting

An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy

Kidney Cancer | Renal Cell Carcinoma | Urothelial Carcinoma | Hereditary Leiomyomatosis and Renal Cell Cancer | Metastatic Urothelial Carcinoma | Chromophobe Renal Cell Carcinoma | Papillary Renal Cell Carcinoma | HLRCC | Clear Cell Carcinoma | Metastatic Kidney Cancer | Fumarate Hydratase Deficiency | Succinate...

United States
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...
Istituto Di Ricerche Farmacologiche Mario Negri

Recruiting

ALBumin Italian Outcome Septic Shock-BALANCED Trial (ALBIOSS-BALANCED) (ALBIOSS-BAL)

Septic Shock

Italy
Repros Therapeutics Inc.

Completed

Extension of Study ZPV-200

Uterine Fibroids

United States
Phoenix Molecular Imaging

Withdrawn

C11-Sodium Acetate PET/CT Imaging Evaluation in Brain Glioma, Post Therapy Necrosis and Pseudo-progression

Gliomas

United States
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Indacaterol Acetate Delivered Via the Concept1 Inhalation Device in Children Greater or Equal to 6 and Less Than 12 Years of Age With Asthma

Asthma

South Africa, Belgium, Croatia, Turkey, Hungary, Colombia, Slovakia, Philippines, Russian Federation, Guatemala, Germany
University of Alabama at Birmingham

Not yet recruiting

Understanding the Metabolic and Functional Derangement of Primary Mitral Regurgitation: a Feasibility Study Using Carbon 11(C-11) Acetate Cardiac Positron Emission Tomography Magnetic Resonance Imaging (PET-MRI)

Mitral Valve Regurgitation

United States
University of Pennsylvania

Terminated

11C-Acetate PET/CT Imaging As a Biomarker of Amyloid-Induced Neuroinflammation

Mild Cognitive Impairment

United States
Rigshospitalet, Denmark
University of Iceland; Octapharma

Completed

Vasculopathic Injury and Plasma as Endothelial Rescue in Septic Shock (SHOCK) Trial (VIPER-SHOCK)

Septic Shock

Denmark

Search clinical trials for: anecortave acetate

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations